How can one gene produce several different proteins?

Through alternative splicing, the exons of a single gene's pre-messenger RNA can be joined in different combinations, producing distinct mature transcripts that may be translated into different protein isoforms. This greatly expands functional diversity without increasing gene number.

Alternative Splicing and Non-Coding RNA Function

Alternative splicing lets a single gene generate multiple distinct messenger RNAs — and often multiple proteins — by joining exons in different combinations, greatly expanding the functional output of the genome. Non-coding RNAs, transcripts that are not translated into protein, add a further regulatory layer, acting on transcription, splicing, RNA stability, and chromatin. Together these phenomena explain how a modest number of genes supports the complexity of the transcriptome.

Definition

Alternative splicing is the regulated process by which different combinations of exons from a single pre-messenger RNA are joined to produce distinct mature transcripts, while non-coding RNA function refers to the regulatory and structural roles of RNA transcripts that are not translated into protein.

Scope

This topic covers the regulated process of alternative splicing (exon inclusion and skipping, splice-site selection, and isoform diversity) and the major classes and functions of non-coding RNA, from small regulatory RNAs to long non-coding RNAs. It is a conceptual and methodological reference within transcriptomics and provides no clinical guidance.

Core questions

How are splice sites recognized and selected so that one gene yields several transcript isoforms?
How does alternative splicing expand proteome and transcriptome diversity?
What are the main classes of non-coding RNA and how do they regulate gene expression?
How do high-throughput methods detect isoforms and quantify non-coding transcripts?

Key concepts

Exons, introns, and the spliceosome
Exon inclusion and skipping
Splice-site and exon definition
Transcript isoform diversity
Small regulatory RNAs (e.g., microRNAs)
Long non-coding RNAs (lncRNAs)
Post-transcriptional regulation
Splicing regulatory elements and factors

Mechanisms

During splicing, the spliceosome removes introns from a pre-messenger RNA and ligates exons; when splice-site choice is regulated, the same pre-mRNA can be processed into different mature transcripts through exon inclusion, exon skipping, or alternative splice-site and start/end usage. Recognition of the correct boundaries depends on splice-site sequences and on regulatory elements bound by splicing factors, which is why exon definition is a finely tuned process, as reviewed by Keren and colleagues. Non-coding RNAs operate through complementary mechanisms: short regulatory RNAs guide repression of target messenger RNAs, while long non-coding RNAs can scaffold protein complexes, guide chromatin modifiers, or modulate transcription, as surveyed by Ponting and colleagues. Genome-wide surveys such as the ENCODE project showed that a large fraction of the genome is transcribed into non-coding RNA, underscoring the breadth of this regulatory layer; sequencing methods that capture splice junctions allow isoforms and non-coding transcripts to be detected and quantified.

Clinical relevance

Aberrant splicing and dysregulated non-coding RNAs are implicated in many diseases and are an area of active biomarker and therapeutic research. As a reference topic this entry explains how isoform and non-coding-RNA biology is described and measured; it is not a basis for individual diagnostic or treatment decisions.

Evidence & guidelines

Reference reviews include Keren and colleagues on alternative splicing and exon definition and Ponting and colleagues on long non-coding RNA function, complemented by genome-wide transcription surveys from the ENCODE project. These are methodological and conceptual references rather than clinical guidelines.

History

The discovery of split genes and RNA splicing in the late 1970s revealed that exons could be combined in alternative ways, and over subsequent decades alternative splicing was recognized as a pervasive source of transcript and protein diversity. In parallel, the study of non-coding RNA expanded from a few well-known functional RNAs to large classes of small regulatory and long non-coding transcripts, and genome-wide projects from the 2000s documented widespread non-coding transcription, reframing much of the genome as functionally transcribed.

Debates

How much non-coding transcription is functional?: Genome-wide surveys show that much of the genome is transcribed into non-coding RNA, but distinguishing transcripts with biological function from transcriptional noise remains contested, and functional annotation of long non-coding RNAs lags behind their discovery.

Key figures

Gil Ast
Chris P. Ponting
Wolf Reik

Seminal works

keren-2010
ponting-2009
encode-2012

Frequently asked questions

How can one gene produce several different proteins?: Through alternative splicing, the exons of a single gene's pre-messenger RNA can be joined in different combinations, producing distinct mature transcripts that may be translated into different protein isoforms. This greatly expands functional diversity without increasing gene number.
If non-coding RNAs are not translated, how do they act?: They function as RNA molecules rather than as templates for protein. Small regulatory RNAs can direct the repression of target messenger RNAs, while long non-coding RNAs can scaffold protein complexes, guide chromatin-modifying machinery, or influence transcription.